AstraZeneca: all 4,196 studies
Page 25 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.CompletedNCT03433924
- A Cross-sectional Study of COPD and Symptom Variability in MEA CountriesCompletedNCT03425760
- A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerCompletedNCT03423628Phase 1
- AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerCompletedNCT03421353Phase 1
- A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy VolunteersCompletedNCT03420092Phase 1
- Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From TurkeyCompletedNCT03407196
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese MenCompletedNCT03400488Phase 1
- The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa AntagonistCompletedNCT03397888Phase 1
- Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid MalignanciesCompletedNCT03394144Phase 1
- Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos StudyCompletedNCT03387722
- A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese DescentCompletedNCT03385369Phase 1
- A Study of Modified Release Formulations of Danicopan in Healthy Adult ParticipantsCompletedNCT03384186Phase 1
- Long-term Observational Study of the Safety of RoflumilastCompletedNCT03381573
- A Study to Evaluate the Symptoms Over 24 Hours in Patients With Chronic Obstructive Pulmonary Disease - LASSYC StudyCompletedNCT03381560
- Treatment and Exacerbation in COPD SubjectsCompletedNCT03375450
- Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)CompletedNCT03373045
- Indian Phenotype RegistryCompletedNCT03363594
- A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple DosesTerminatedNCT03362593Phase 1
- Long-Term Follow-Up and Management Patterns of Patients With Acute Coronary Syndrome in Middle East and AfricaCompletedNCT03362463
- Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD PatientsCompletedNCT03359122
- Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382CompletedNCT03347968Phase 1
- A Phase IV Study in Drug-Naive Patients With T2DM in ChinaTerminatedNCT03344341Phase 4
- A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382CompletedNCT03341013Phase 1
- Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced CancerCompletedNCT03333824Phase 1
- A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)CompletedNCT03333018
- A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Active, not recruitingNCT03328273Phase 1
- Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid TumoursCompletedNCT03315091Phase 1
- AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology StudiesCompletedNCT03313557Phase 1
- A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects.CompletedNCT03313336Phase 1
- Study to Determine if AZD0284 is Effective and Safe in Treating Plaque PsoriasisTerminatedNCT03310320Phase 1
- Assessment of Asthma Control Level in MalaysiaCompletedNCT03295331
- Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular EndpointsCompletedNCT03290287
- A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)CompletedNCT03283267Phase 1
- To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled CorticosteroidsCompletedNCT03273127Phase 1
- Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.CompletedNCT03272425Phase 1
- Single Ascending Dose Study of MEDI1341 in Healthy VolunteersCompletedNCT03272165Phase 1
- Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesCompletedNCT03263637Phase 1
- An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1Approved for marketingNCT03259633
- A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy VolunteersCompletedNCT03258515Phase 1
- Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.CompletedNCT03236974Phase 1
- A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment SubjectsCompletedNCT03235375Phase 1
- Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCACompletedNCT03229122
- Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.CompletedNCT03219970
- Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.TerminatedNCT03218683Phase 1
- Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor AntidoteCompletedNCT03218241Phase 1
- Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.TerminatedNCT03217838Phase 1
- The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed ConditionsCompletedNCT03216278Phase 1
- AZD1390 Administration of a Microdose [11C]AZD1390 to Healthy VolunteersCompletedNCT03215381Phase 1
- Brilinta Clinical Experience InvestigationCompletedNCT03212287
- Type 2 Diabetes Mellitus Patients' Characteristics and Management by General Practitioners and EndocrinologistsCompletedNCT03209089
- AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasCompletedNCT03205176Phase 1
- China Ovarian Cancer BRCA Testing StudyTerminatedNCT03203993
- A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell MalignanciesCompletedNCT03198650Phase 1
- A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate CancerCompletedNCT03193060
- Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)CompletedNCT03189875
- To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary DiseaseWithdrawnNCT03181880Phase 4
- A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.CompletedNCT03169959Phase 1
- Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese SubjectsCompletedNCT03159442Phase 1
- Patients' Compliance to Home Nebulizer Therapy for Children's Asthma in ChinaCompletedNCT03156998
- Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in ChinaCompletedNCT03156985
- A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898TerminatedNCT03140072Phase 1
- Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy SubjectsCompletedNCT03138356Phase 1
- Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive PatientsCompletedNCT03137264
- A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular DiseaseCompletedNCT03136991Phase 1
- Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLCCompletedNCT03133234
- Realize the Current Situation of COPD Patients in ChinaCompletedNCT03131362
- A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are AdministeredCompletedNCT03126695Phase 1
- Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese PopulationCompletedNCT03118778
- A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy ParticipantsCompletedNCT03108274Phase 1
- A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological MalignanciesCompletedNCT03106428Phase 1
- Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid TumoursCompletedNCT03101839Phase 1
- PET Study to Determine Muscarinic Receptor Occupancy in Lungs After Inhalation of AZD2115 and TiotropiumCompletedNCT03097380Phase 1
- Safety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese ParticipantsCompletedNCT03096795Phase 1
- A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DMCompletedNCT03090464
- MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.CompletedNCT03089645Phase 1
- Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in TaiwanCompletedNCT03084965
- A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet AlfaCompletedNCT03083704Phase 1
- Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf RegionCompletedNCT03082976
- To Assess the Efficacy and Safety of PT010 Compared to PT009 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseWithdrawnNCT03081247Phase 3
- Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.Approved for marketingNCT03079687
- Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory DataCompletedNCT03078049
- International Breast Cancer Biomarker,Standard of Care and Real World Outcomes StudyCompletedNCT03078036
- Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian PatientsCompletedNCT03071016
- Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in JapanNo longer availableNCT03063710
- Outcomes in UK ACS Patients Prescribed TicagrelorCompletedNCT03058601
- Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)TerminatedNCT03053297
- XIGDUO Extended Release (XR) Post Marketing SurveillanceCompletedNCT03038789
- Asia PDL1 Study Among NSCLC PatientsCompletedNCT03037086
- Symptoms and Physical Activity in COPD Patients in EuropeCompletedNCT03031769
- Bioavailability of AZD0284 and IV Microtracer StudyCompletedNCT03029741Phase 1
- Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.WithdrawnNCT03028909Phase 2
- A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).CompletedNCT03022409Phase 1
- Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884CompletedNCT03001297Phase 1
- Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 InhibitorsCompletedNCT02993614
- A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate CancerCompletedNCT02991911Phase 1
- ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central LaboratoryCompletedNCT02991274
- Study of Samalizumab in Patients With Advanced CancerTerminatedNCT02987504Phase 1
- Clinical Outcomes of Exenatide Versus Basal InsulinCompletedNCT02987348
- FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic StudyCompletedNCT02984423
- A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced MalignanciesCompletedNCT02978482Phase 1